Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis

Clin Exp Rheumatol. Mar-Apr 2006;24(2 Suppl 41):S106.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Etanercept
  • Female
  • Humans
  • IgA Vasculitis / chemically induced*
  • IgA Vasculitis / pathology
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use*
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Tumor Necrosis Factor-alpha / analysis
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Vasculitis / pathology

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept